Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bluebird Bio (BLUE)

Bluebird Bio (BLUE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,890,690
  • Shares Outstanding, K 67,141
  • Annual Sales, $ 250,730 K
  • Annual Income, $ -618,700 K
  • 60-Month Beta 1.78
  • Price/Sales 7.73
  • Price/Cash Flow N/A
  • Price/Book 1.41
Trade BLUE with:

Options Overview

Details
  • Implied Volatility 71.84%
  • Historical Volatility 57.27%
  • IV Percentile 59%
  • IV Rank 26.68%
  • IV High 124.24% on 03/26/21
  • IV Low 52.77% on 01/21/21
  • Put/Call Vol Ratio 0.21
  • Today's Volume 2,136
  • Volume Avg (30-Day) 3,451
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 35,814
  • Open Int (30-Day) 36,795

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -3.05
  • Number of Estimates 13
  • High Estimate -2.79
  • Low Estimate -3.40
  • Prior Year -3.64
  • Growth Rate Est. (year over year) +16.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.44 +2.62%
on 03/25/21
34.50 -18.38%
on 03/10/21
-1.88 (-6.26%)
since 03/09/21
3-Month
24.24 +16.17%
on 02/23/21
53.68 -47.54%
on 01/12/21
-20.38 (-41.99%)
since 01/08/21
52-Week
24.24 +16.17%
on 02/23/21
72.50 -61.16%
on 06/05/20
-18.34 (-39.44%)
since 04/09/20

Most Recent Stories

More News
FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / April 12, 2021 / , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against bluebird bio, Inc. ("bluebird" or "the Company")...

BLUE : 28.16 (-2.46%)
BLUE Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds bluebird bio, Inc. Investors of Class Action and Lead Plaintiff Deadline April 13, 2021

NEW YORK, NY / ACCESSWIRE / April 11, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ:BLUE)...

BLUE : 28.16 (-2.46%)
TUESDAY DEADLINE ALERT: ROSEN, A TOP RANKED FIRM, Encourages bluebird bio, Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action - BLUE

, /PRNewswire/ --

BLUE : 28.16 (-2.46%)
DEADLIINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against bluebird bio, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, Reminds Investors that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts...

BLUE : 28.16 (-2.46%)
BLUE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 13, 2021 in the Class Action Filed on Behalf of bluebird bio, Inc. Limited Shareholders

New York, New York--(Newsfile Corp. - April 9, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of bluebird bio, Inc. (NASDAQ: BLUE) alleging...

BLUE : 28.16 (-2.46%)
BLUE FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages bluebird bio, Inc. Investors With Losses to Secure Counsel Before Important Tuesday Deadline in Securities Class Action - BLUE

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of bluebird bio, Inc. (NASDAQ: BLUE) between May 11, 2020 and November 4, 2020, inclusive (the "Class Period")...

BLUE : 28.16 (-2.46%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of bluebird bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 13, 2021 - BLUE

New York, New York--(Newsfile Corp. - April 9, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:

BLUE : 28.16 (-2.46%)
4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / April 9, 2021 / , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against bluebird bio, Inc. ("bluebird" or "the Company") for...

BLUE : 28.16 (-2.46%)
LAWSUITS FILED AGAINST BLUE, VRM and KDMN - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / April 9, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who...

BLUE : 28.16 (-2.46%)
VRM : 40.34 (+1.51%)
KDMN : 3.66 (-4.94%)
TUESDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - April 9, 2021) - , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against bluebird bio, Inc. ("bluebird" or "the Company")...

BLUE : 28.16 (-2.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio,...

See More

Key Turning Points

3rd Resistance Point 29.53
2nd Resistance Point 29.13
1st Resistance Point 28.65
Last Price 28.16
1st Support Level 27.77
2nd Support Level 27.37
3rd Support Level 26.89

See More

52-Week High 72.50
Fibonacci 61.8% 54.07
Fibonacci 50% 48.37
Fibonacci 38.2% 42.68
Last Price 28.16
52-Week Low 24.24

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar